Response to “On the reproducibility of quantitative susceptibility mapping and its potential as a clinical biomarker: A comment on Cogswell et al. 2021”
Petrice M. Cogswell,
Heather J. Wiste,
Stephen D. Weigand,
Terry M. Therneau,
Clifford R. Jack, Jr
Affiliations
Petrice M. Cogswell
Department of Radiology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA; Corresponding author at: 200 First St SW, Rochester, MN 55905, USA.
Heather J. Wiste
Department of Health Sciences Research, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
Stephen D. Weigand
Department of Health Sciences Research, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
Terry M. Therneau
Department of Health Sciences Research, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
Clifford R. Jack, Jr
Department of Radiology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
